KAPA fundamentals
An in-depth look to Kairos Pharma, Ltd. operating, investing, and financing activities
KAPA free cash flow for Q3 24 is -2.02 M USD. For 2023, KAPA free cash flow was 81 k USD and operating cash flow was 81 k USD.
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM